论文信息 - Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan - 字舞流文

Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan

J. Kuroda | K. Izutsu | K. Ando | Koji Kato | T. Teshima | Y. Imaizumi | H. Shibayama | R. Sakai | S. Hojo | Shinya Rai | Tadashi Nakanishi | K. Nosaka | M. Nishikori